Listed on the TSX Venture Exchange (TSXV: RX), BioSyent is a profitable growth oriented specialty pharmaceutical company focused on in-licensing or acquiring innovative pharmaceutical products that have been successfully developed, are proven safe and effective, and have track records of improving the lives of patients. BioSyent supports the healthcare professionals that treat these patients by marketing its products through its community, hospital, and international business units.
BioSyent continues to search for products to in-license or acquire that match the following criteria:
- Are unique and occupy a niche in the market;
- Provide novel technological or therapeutic advantages to patients and healthcare professionals;
- Are backed by strong partners who hold defendable intellectual property rights.
|
Backed by the success of our products, for three consecutive years (2012, 2013 & 2014) BioSyent was named to the TSX Venture Top 50 strong performing companies. |
| |
|
|
|
BioSyent has been named one of Canada’s fastest growing companies by PROFIT Magazine in 2013, 2014, 2015, 2016, 2017, 2018, 2019 and 2020.
|
FeraMAX® is the #1 iron supplement recommended by both Canadian Pharmacists and Physicians for the seventh year in a row! Visit FeraMAX.com
|
|
`
Click here to read more
|
Ensemble IQ survey:†Pharmacy Practice+ and Profession Santé and The Medical Post and Profession Santé 2022 Survey on OTC Counselling and Recommendations
FeraMAX® is a registered trademark of BioSyent Pharma Inc.
| 
